m-TOR inhibitor as potential radiosensitizer for head and neck squamous cell carcinoma: A case report of an organ transplant patient and review of the literature

Oral Oncol. 2016 Nov:62:e1-e2. doi: 10.1016/j.oraloncology.2016.08.008. Epub 2016 Aug 30.

¹ Department of Medical Oncology, Saint-André Hospital, University Hospital, CHU Bordeaux, France; Bordeaux University, Bordeaux, France. Electronic address: [email protected].
² Department of Otolaryngology - Head and Neck Surgery, Pellegrin Hospital, University Hospital, CHU Bordeaux, France.
³ Department of Radiation Therapy, Haut Leveque Hospital, University Hospital, CHU Bordeaux, France.
⁴ Department of Medical Oncology, Saint-André Hospital, University Hospital, CHU Bordeaux, France; Bordeaux University, Bordeaux, France.
⁵ Department of Medical Oncology, Saint-André Hospital, University Hospital, CHU Bordeaux, France.

No abstract available

Keywords: Cetuximab; Head and neck squamous cell carcinoma; Organ transplant; Radiation skin toxicity; m-TOR inhibitor.

Publication types